The Task-force in Europe for Drug Development for the Young (TEDDY) Network of Excellence

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.11, Iss.1, 2009-01, pp. : 18-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incentives for paediatric drug development in Europe

Inpharma, Vol. 1, Iss. 1506, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Targeting Outpatient Drug Safety: Recommendations of the Dutch HARM-Wrestling Task Force

By Herwaarden Margaretha F. Warlé-van

Drug Safety, Vol. 35, Iss. 3, 2012-03 ,pp. : 245-259

Adis International

Access to resources Recommend Favorite

Radiopharmaceuticals, Drug Development and Pharmaceutical Regulations in Europe

Current Radiopharmaceuticals, Vol. 1, Iss. 1, 2008-01 ,pp. : 7-11

Bentham Science Publishers

Access to resources Recommend Favorite

CAST Task Force Reports and ISRTP

By Carr C.J. Fogleman R.W.

Regulatory Toxicology and Pharmacology, Vol. 25, Iss. 3, 1997-06 ,pp. : 203-203

Academic Press

Access to resources Recommend Favorite

US Task Force advises against use of HRT

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 386, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite